Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1991-06-13
1993-04-13
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
5142378, 514253, 514321, 514338, 514411, 514826, 514886, 544 60, 544111, 544372, 546189, 546194, 546198, 548431, 548436, C07D40100, A61K 3154
Patent
active
052023214
ABSTRACT:
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, psoriasis, uveitis and allograft rejection and in preventing the formation of atherosclerotic plaques.
REFERENCES:
patent: 5021420 (1991-06-01), Comte et al.
Delorme Daniel
Fortin Rejean
Girard Yves
Hamel Pierre
Hutchinson John H.
Covington Raymond
DiPrima Joseph F.
Ivy C. Warren
Lopez Gabriel
Merck Frosst Canada Inc.
LandOfFree
Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosyn does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosyn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosyn will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1155520